An integrative proteotranscriptomics approach reveals new ADAM9 substrates and downstream pathways.

Summary

We developed a new proteotranscriptomics method to identify targets of membrane protein shedding enzymes called sheddases. This approach revealed ADAM9 sheddase substrates and downstream signaling pathways involved in diseases like cancer and COVID-19.